Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
Prünte C, Fajnkuchen F, Mahmood S, Ricci F, Hatz K, Studnička J, Bezlyak V, Parikh S, Stubbings WJ, Wenzel A, Figueira J; RETAIN Study Group. Prünte C, et al. Among authors: wenzel a. Br J Ophthalmol. 2016 Jun;100(6):787-95. doi: 10.1136/bjophthalmol-2015-307249. Epub 2015 Oct 9. Br J Ophthalmol. 2016. PMID: 26453639 Free PMC article. Clinical Trial.
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.
Larsen M, Waldstein SM, Boscia F, Gerding H, Monés J, Tadayoni R, Priglinger S, Wenzel A, Barnes E, Pilz S, Stubbings W, Pearce I; CRYSTAL Study Group. Larsen M, et al. Among authors: wenzel a. Ophthalmology. 2016 May;123(5):1101-11. doi: 10.1016/j.ophtha.2016.01.011. Epub 2016 Feb 17. Ophthalmology. 2016. PMID: 26896124 Free article. Clinical Trial.
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.
Tadayoni R, Waldstein SM, Boscia F, Gerding H, Gekkieva M, Barnes E, Das Gupta A, Wenzel A, Pearce I; BRIGHTER Study Group. Tadayoni R, et al. Among authors: wenzel a. Ophthalmology. 2017 Dec;124(12):1778-1787. doi: 10.1016/j.ophtha.2017.06.027. Epub 2017 Aug 12. Ophthalmology. 2017. PMID: 28807635 Free article. Clinical Trial.
Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.
Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, Wenzel A, Barnes E, Gekkieva M, Pilz S, Monés J; BRIGHTER study group. Tadayoni R, et al. Among authors: wenzel a. Ophthalmology. 2016 Jun;123(6):1332-44. doi: 10.1016/j.ophtha.2016.02.030. Epub 2016 Mar 30. Ophthalmology. 2016. PMID: 27039022 Free article. Clinical Trial.
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Holz FG, Dugel PU, Weissgerber G, Hamilton R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A, Schmidt A, Escher D, Sararols L, Souied E. Holz FG, et al. Among authors: wenzel a. Ophthalmology. 2016 May;123(5):1080-9. doi: 10.1016/j.ophtha.2015.12.030. Epub 2016 Feb 20. Ophthalmology. 2016. PMID: 26906165 Free article. Clinical Trial.
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study.
Larsen M, Waldstein SM, Priglinger S, Hykin P, Barnes E, Gekkieva M, Das Gupta A, Wenzel A, Monés J; CRYSTAL Study Group. Larsen M, et al. Among authors: wenzel a. Ophthalmol Retina. 2018 Feb;2(2):134-142. doi: 10.1016/j.oret.2017.05.016. Epub 2017 Sep 9. Ophthalmol Retina. 2018. PMID: 31047340 Free article. Clinical Trial.
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials.
Dugel PU, Hillenkamp J, Sivaprasad S, Vögeler J, Mousseau MC, Wenzel A, Margaron P, Hashmonay R, Massin P. Dugel PU, et al. Among authors: wenzel a. Clin Ophthalmol. 2016 Jun 14;10:1103-10. doi: 10.2147/OPTH.S100764. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27366049 Free PMC article.
Reply.
Staurenghi G, Lai TYY, Mitchell P, Wolf S, Wenzel A, Li J, Bhaumik A, Hykin PG; PROMETHEUS study group. Staurenghi G, et al. Among authors: wenzel a. Ophthalmology. 2019 Jun;126(6):e45-e46. doi: 10.1016/j.ophtha.2018.12.019. Ophthalmology. 2019. PMID: 31122370 No abstract available.
Reply.
Staurenghi G, Lai TYY, Mitchell P, Wolf S, Wenzel A, Li J, Bhaumik A, Hykin PG; PROMETHEUS study group. Staurenghi G, et al. Among authors: wenzel a. Ophthalmology. 2019 Jun;126(6):e43-e44. doi: 10.1016/j.ophtha.2018.12.021. Ophthalmology. 2019. PMID: 31122367 No abstract available.
673 results